Table 2.
Pulmonary TB (n = 133) | Non-TB CAP (n = 133) | p value | NPV | PPV | |
---|---|---|---|---|---|
GGO | 96 (72) | 99 (75) | 0.603 | 0.471 | 0.492 |
Consolidation | 97 (73) | 87 (66) | 0.215 | 0.556 | 0.527 |
Cavity | 27 (20) | 11 (8) | 0.005 | 0.533 | 0.711 |
Nodule | 35 (26) | 16 (12) | 0.003 | 0.542 | 0.686 |
Distributions of GGO and/or consolidation | |||||
Number of segments | 3 (2–5) | 2 (1–3) | < 0.001 | ||
Bilateral lungs | 119 (90) | 118 (89) | 0.983 | 0.500 | 0.502 |
Right lung | 107 (81) | 101 (77) | 0.436 | 0.544 | 0.514 |
Left lung | 85 (64) | 64 (49) | 0.011 | 0.586 | 0.570 |
Upper field | 101 (76) | 62 (47) | < 0.001 | 0.686 | 0.620 |
Middle field | 94 (71) | 74 (56) | 0.014 | 0.598 | 0.560 |
Lower field | 91 (68) | 97 (74) | 0.364 | 0.455 | 0.484 |
Data are presented as number (%).
CAP community-acquired pneumonia, TB tuberculosis, NPV negative predictive value, PPV positive predictive value, GGO ground-glass opacities.